Carl June

Director/Board Member at AC IMMUNE SA

Net worth: 179 699 $ as of 2026-05-30

72 year

89 connections

Finance

Commercial Services

Consumer Services

Profile

Carl H.
June is the founder of Tmunity Therapeutics, Inc. Dr. June is Director at the American Association for Cancer Research since 2018.
Dr. June is Director at The Parker Institute For Cancer Immunotherapy.
Dr. June is Independent Director at AC Immune SA since 2020.
Dr. June is Senior Advisor at Arsenal Capital Management LP.
Formerly, Dr. June was Advisor at Signature Capital LLC and Advisor at GBP Capital.
Dr. June earned a doctorate from Baylor College of Medicine in 1979 and an undergraduate degree from the United States Naval Academy in 1975.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AC IMMUNE SA 0.07%	2026-06-10	67,556 ( 0.07% )	179 699 $	2026-05-30

Carl June active positions

Companies	Position	Start
AC IMMUNE SA	Director/Board Member	2020-11-19
Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company	Founder	-
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Director/Board Member	2017-12-31
The Parker Institute For Cancer Immunotherapy The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research	Director/Board Member	-
Arsenal Capital Management LP Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions.	Consultant / Advisor	-

All active positions of Carl June

Former positions of Carl June

Companies	Position	End
Signature Capital LLC Signature Capital LLC Investment ManagersFinance Signature invests in early-stage growth technology companies in the following areas: electronic equipment/devices, application-specific semiconductor products, telecommunications, medical/biotechnology (healthcare products or therapies), Internet businesses and technology based service companies. They look for companies that have a proprietary position in timely new products or services and serve a large, established market that will allow rapid scalability of revenue to over $100 million per year. The company must strong, visionary managers and be in a field with good valuations in the securities markets	Corporate Officer/Principal	-
GBP Capital GBP Capital Investment ManagersFinance GBP Capital provides venture funding and assistance to early and mid-stage life science companies. They target companies with unique approaches to diagnostics, therapeutics and medical devices. GBP Capital focuses on investing in companies with technologies that leverage and build upon medical breakthroughs, as well as other major developments taking place within the life-sciences industry.	Private Equity Investor	-

See the detail of Carl June's experience

Training of Carl June

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carl June's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
AC Immune SA AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases	Health Technology
Arsenal Capital Management LP Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions.	Finance
Signature Capital LLC Signature Capital LLC Investment ManagersFinance Signature invests in early-stage growth technology companies in the following areas: electronic equipment/devices, application-specific semiconductor products, telecommunications, medical/biotechnology (healthcare products or therapies), Internet businesses and technology based service companies. They look for companies that have a proprietary position in timely new products or services and serve a large, established market that will allow rapid scalability of revenue to over $100 million per year. The company must strong, visionary managers and be in a field with good valuations in the securities markets	Finance
United States Naval Academy United States Naval Academy Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Baylor College of Medicine Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Commercial Services
GBP Capital GBP Capital Investment ManagersFinance GBP Capital provides venture funding and assistance to early and mid-stage life science companies. They target companies with unique approaches to diagnostics, therapeutics and medical devices. GBP Capital focuses on investing in companies with technologies that leverage and build upon medical breakthroughs, as well as other major developments taking place within the life-sciences industry.	Finance
Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company	Commercial Services
The Parker Institute For Cancer Immunotherapy The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research	Commercial Services